A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/127
A61K 33/24 (2006.01) A61K 33/26 (2006.01)
Patent
CA 1277912
ABSTRACT OF THE DISCLOSURE The present invention relates to radiosensi- tization and, more particularly, to rendering hypoxic cells more sensitive to being killed by X-rays or other forms of irradiation. The specification discloses a pharmaceutical method and a composition containing a radiosensitizing amount of a Co(III) or Fe(III) coordination compound, selected from the group con- sisting of: (1) compounds having the formula - [CoNnX6-n]Y where n has a value of 3 or 4; N is an uncharged nitrogen donor atom that is contained in a ligand; X represents an anionic ligand; and y represents the charge on the complex; (2) compounds having the formula [CoA2X1D]Y where A represents a bidentate or tetradentate negative ligand containing N or O donor atoms; X and D represent the same or different monodentate ligands; and y1 represents a positive or negative charge on the complex; (3) compounds having the formula [CoZ3] where Z represents a chelating mononegative ligand; and (4) compounds of the formula [Fe TT1]+ where T and T1, which may be the same or different, represent mono-negative tridentate ligands.
520975
Abrams Michael J.
Teicher Beverly A.
Abrams Michael J.
Dana-Farber Cancer Institute Inc.
Gowling Lafleur Henderson Llp
Johnson Mattey Inc.
Teicher Beverly A.
LandOfFree
Radiosensitization by cobalt and fe (iii) complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiosensitization by cobalt and fe (iii) complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiosensitization by cobalt and fe (iii) complexes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1207221